Sinovac became a "savior" in a Southeast Asian country

Sinovac became a "savior" in a Southeast Asian country: Thousands of people are allergic to Pfizer and Moderna mRNA vaccines

By August 29, Singapore's Ministry of Health had contacted about 7,100 people who had an allergic reaction to the first dose of the mRNA vaccine and recommended a second injection with China's Sinovac vaccine.

Sinovac became a "savior" in a Southeast Asian country
Sinovac became a "savior" in a Southeast Asian country

The Independent (Singapore) reported that these people had received the first Covid-19 vaccine with vaccines from Pfizer or Moderna - two vaccines that have been approved for emergency use by Singapore.

Sinovac and Sinopharm, two Chinese-made vaccines, have also been approved for use in Singapore through a special route. The vaccines are given at private healthcare facilities and the injectors pay a fee, while the vaccines from Pfizer and Moderna are provided free of charge by the authorities.

Singapore's Ministry of Health said that of those contacted to recommend the Sinovac vaccine, 3,900 people expressed interest in getting the Chinese vaccine.

Under this program, more than 1,100 people have received one shot and about 570 people have fully received two doses of Sinovac vaccine.

"Since the beginning of July, the Ministry of Health [Singapore] has recommended that people receive the 1st dose of the Covid-19 vaccine using mRNA technology, but because of medical reasons, the 2nd dose cannot be given due to allergies. Sinovac-CoronaVac vaccine at 4 public health facilities," Today Online (Singapore) page on September 5 quoted information from the Singapore Ministry of Health.

Sinovac and Sinopharm's vaccines are developed using inactivated virus technology, while Pfizer and Moderna currently offer mRNA-based vaccines.

Singapore's Deputy Health Minister Janil Puthucheary said those who must receive Sinovac vaccine due to an allergy to the mRNA vaccine will be determined to be fully vaccinated after completing the Sinovac injection.

Earlier this month, Singapore's Ministry of Health announced that 200,000 doses of the Sinovac vaccine had been allocated and that the new batch of vaccine was expected to arrive in the country within four to six weeks.

In which, in addition to 170,000 doses allocated to private medical facilities, 30,000 doses have been prophylactic for Singaporeans, permanent residents, etc. with mRNA vaccine allergy, as well as for other purposes.

Google Tech News

Post a Comment

Previous Post Next Post